Akari receives positive Pre-IND feedback from FDA for PAS-nomacopan
PremiumThe FlyAkari receives positive Pre-IND feedback from FDA for PAS-nomacopan
3M ago
Akari Therapeutics announces interm CEO employment contract
Premium
The Fly
Akari Therapeutics announces interm CEO employment contract
5M ago
Akari Therapeutics reports Q1 EPS 0c vs 0c last year
Premium
The Fly
Akari Therapeutics reports Q1 EPS 0c vs 0c last year
6M ago
Akari CEO Jacques, COO Bradford-Klug step down, appoints Patel as interim CEO
PremiumThe FlyAkari CEO Jacques, COO Bradford-Klug step down, appoints Patel as interim CEO
6M ago
Akari Therapeutics Announces Strategic Merger with Peak Bio
Premium
Company Announcements
Akari Therapeutics Announces Strategic Merger with Peak Bio
8M ago
Akari Therapeutics, Peak Bio announce definitive agreement to merge as equals
Premium
The Fly
Akari Therapeutics, Peak Bio announce definitive agreement to merge as equals
8M ago
Akari Therapeutics expects cash to fund operations into 1Q24
PremiumThe FlyAkari Therapeutics expects cash to fund operations into 1Q24
1y ago
Akari Therapeutics reports 1H EPS 0c vs. 0c last year
Premium
The Fly
Akari Therapeutics reports 1H EPS 0c vs. 0c last year
1y ago
Akari Therapeutics enters definitive purchase agreements with existing investors
Premium
The Fly
Akari Therapeutics enters definitive purchase agreements with existing investors
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100